- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06426069
Assessment of Masticatory Performance in Periodontitis
Assessment of Masticatory Performance in Various Stages of Periodontitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Periodontal disease manifestations include gingival bleeding, halitosis, tooth mobility and loss of teeth in advanced cases. The loss of periodontal attachment contributes to reduced masticatory performance and has a negative impact on general health. Loss of periodontium leads to reduced ability of tooth to withstand masticatory loads. Thus, biting abilities of subjects with healthy periodontium are significantly greater than those of chronic periodontitis patients. Even though the new periodontitis classification includes masticatory dysfunction in stage 4, but clinical periodontal parameters do start influencing objective masticatory efficiency in early stages. Since the masticatory function is an important point for the classification of periodontitis, standardized procedures with corresponding reference values are needed to consider these parameters in the assessment of periodontitis and to be able to make specific therapy recommendations.
This clinical trial aims to assess the changes in masticatory performance among periodontitis patients of all stages and healthy individuals using test methods easily applicable in daily practice.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rajinder K Sharma, MDS
- Phone Number: 09416358222
- Email: rksharmamds@yahoo.in
Study Contact Backup
- Name: Janvi Janvi, BDS
- Phone Number: 09416183623
- Email: janvisahu75@gmail.com
Study Locations
-
-
Haryana
-
Rohtak, Haryana, India, 124001
- Post Graduate Institute of Dental Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients with age group 30-50 years diagnosed with generalized periodontitis
- Presence of minimum 20 teeth (Eichner group A1, A2, A3) excluding third molars.
Exclusion Criteria:
- Systemic diseases that may affect periodontal disease progression or outcome of treatment (diabetes, autoimmune diseases)
- Systemic diseases that may affect masticatory ability of the patient (sarcopenia, TMJ disorders, Xerostomia, Acute Pulpitis)
- Grade C periodontitis (evaluated indirectly by radiographic bone loss/age criteria)
- Smoking or substance abuse
- Pregnant and lactating women
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Periodontally Healthy
Complete periodontal examination will be done comprising of recording pocket probing depth (PPD), clinical attachment level (CAL) at six sites per tooth, bleeding on probing (BOP), plaque index (PI) and gingival index (GI) and mobility.
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum.
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire.
|
Masticatory efficiency will be assessed for each group.
|
Stage I Periodontitis
Complete periodontal examination will be done comprising of recording pocket probing depth (PPD), clinical attachment level (CAL) at six sites per tooth, bleeding on probing (BOP), plaque index (PI) and gingival index (GI) and mobility.
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum.
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire.
|
Masticatory efficiency will be assessed for each group.
|
Stage II Periodontitis
Complete periodontal examination will be done comprising of recording pocket probing depth (PPD), clinical attachment level (CAL) at six sites per tooth, bleeding on probing (BOP), plaque index (PI) and gingival index (GI) and mobility.
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum.
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire.
|
Masticatory efficiency will be assessed for each group.
|
Stage III Periodontitis
Complete periodontal examination will be done comprising of recording pocket probing depth (PPD), clinical attachment level (CAL) at six sites per tooth, bleeding on probing (BOP), plaque index (PI) and gingival index (GI) and mobility.
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum.
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire.
|
Masticatory efficiency will be assessed for each group.
|
Stage IV Periodontitis
Complete periodontal examination will be done comprising of recording pocket probing depth (PPD), clinical attachment level (CAL) at six sites per tooth, bleeding on probing (BOP), plaque index (PI) and gingival index (GI) and mobility.
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum.
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire.
|
Masticatory efficiency will be assessed for each group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective masticatory performance
Time Frame: Baseline
|
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum, through optoelectronic analysis using a software.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective masticatory performance
Time Frame: Baseline
|
Subjective masticatory performance will be calculated using The Quality of Masticatory Function Questionnaire which consists of 29 questions related to frequency and difficulty of chewing different types of foods in the previous 2 weeks.
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Janvi Janvi, BDS, pgids rohtak
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JANVIPERIO2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on Masticatory efficiency assessment
-
Bahçeşehir UniversityOndokuz Mayıs UniversityCompleted
-
Clinical Hospital Center RijekaRecruiting
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
National Taiwan University HospitalRecruitingPalatal Masticatory Mucosa ThicknessTaiwan
-
Centre Hospitalier Sud FrancilienAvailable
-
The University of Hong KongRecruiting
-
University Rovira i VirgiliCompletedTemporomandibular Joint Disorders | Hamstring Injury | StretchSpain
-
Michigan State UniversityUniversity of MichiganCompletedCardiovascular Diseases in Old Age
-
Johns Hopkins UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedAsthmaUnited States